• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡总医院内科治疗患者中慢性肝病对静脉血栓栓塞的影响。

The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.

作者信息

Yang Yong, Zhang Xiao Zhu, Ng Han Seong, Fong Jeffrey Chern Hui, Lee Lai Heng

机构信息

Department of Epidemiology, Singapore General Hospital, Outram Road, 169608, Singapore; Centre for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore.

Department of Epidemiology, Singapore General Hospital, Outram Road, 169608, Singapore.

出版信息

Thromb Res. 2015 Sep;136(3):548-51. doi: 10.1016/j.thromres.2015.06.033. Epub 2015 Jul 6.

DOI:10.1016/j.thromres.2015.06.033
PMID:26164397
Abstract

BACKGROUND

Chronic liver disease (CLD) has been suggested to be associated with venous thromboembolism (VTE) in western populations. However, little is known about the risk effects of CLD on VTE among Asians.

OBJECTIVE

To compute the prevalence of VTE among hospitalised Asian patients, and to evaluate the pattern and scale of risk effects of CLD on VTE occurrence.

METHOD

Retrospective study of hospital discharge database from 2004 to 2011 to identify patients with VTE and CLD using International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Australian Modification (ICD-9-AM) codes.

RESULTS

Of 199904 medically managed inpatients during the 8years, 1744 (0.9%) patients had VTE. Patients with CLD had significant higher prevalence of VTE (non-cirrhosis CLD 1.5%, cirrhosis 2.0%) than patients without CLD (0.8%, p<0.001). In the logistic regression analyses, non-cirrhosis CLD (odds ratio, OR 1.4, 95% CI 1.2-1.7, p<0.001) and cirrhosis (OR 1.5, 95% CI 1.2-2.0, p=0.002) were significant predictors of VTE after adjustment for age, gender, ethnicity, hospital long stayer, cancer, infectious disease, and other comorbid conditions such as diabetic mellitus, anaemia, and cardiovascular, cerebrovascular, renal and pulmonary diseases.

CONCLUSION

CLD, particular liver cirrhosis, increases the risks of VTE in hospitalised Asian patients. As CLD patients are perceived to be at risks of bleeding due to the prolonged clotting times and thrombocytopenia, the results of this study brings attention to opposite end of the haemostatic pendulum in patients with chronic liver disease.

摘要

背景

在西方人群中,慢性肝病(CLD)被认为与静脉血栓栓塞症(VTE)有关。然而,关于CLD对亚洲人VTE的风险影响知之甚少。

目的

计算住院亚洲患者中VTE的患病率,并评估CLD对VTE发生的风险影响模式和程度。

方法

对2004年至2011年医院出院数据库进行回顾性研究,使用《国际疾病和相关健康问题统计分类,第9次修订版,澳大利亚修订本》(ICD-9-AM)编码识别VTE和CLD患者。

结果

在8年期间接受医学治疗的199904名住院患者中,1744名(0.9%)患者发生了VTE。CLD患者的VTE患病率(非肝硬化CLD为1.5%,肝硬化为2.0%)显著高于无CLD患者(0.8%,p<0.001)。在逻辑回归分析中,调整年龄、性别、种族、长期住院患者、癌症、传染病以及糖尿病、贫血和心血管、脑血管、肾脏和肺部疾病等其他合并症后,非肝硬化CLD(比值比,OR 1.4,95%CI 1.2-1.7,p<0.001)和肝硬化(OR 1.5,95%CI 1.2-2.0,p=0.002)是VTE的显著预测因素。

结论

CLD,尤其是肝硬化,增加了住院亚洲患者发生VTE的风险。由于CLD患者因凝血时间延长和血小板减少而被认为有出血风险,本研究结果引起了对慢性肝病患者止血平衡另一端的关注。

相似文献

1
The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.新加坡总医院内科治疗患者中慢性肝病对静脉血栓栓塞的影响。
Thromb Res. 2015 Sep;136(3):548-51. doi: 10.1016/j.thromres.2015.06.033. Epub 2015 Jul 6.
2
Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.慢性肝病患者发生静脉血栓栓塞的风险及静脉血栓栓塞预防的效用
Ann Pharmacother. 2012 Jun;46(6):873-8. doi: 10.1345/aph.1Q726. Epub 2012 May 8.
3
Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.评估慢性肝病患者的静脉血栓栓塞症药物预防。
Pharmacotherapy. 2013 Apr;33(4):375-82. doi: 10.1002/phar.1218.
4
Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.癌症患者静脉血栓栓塞的家族史与住院血栓栓塞风险:一项全国性家族研究
Thromb Res. 2015 Sep;136(3):573-81. doi: 10.1016/j.thromres.2015.07.004. Epub 2015 Jul 14.
5
Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.评估慢性肝脏疾病患者的静脉血栓栓塞症预防措施。
J Hosp Med. 2013 Oct;8(10):569-73. doi: 10.1002/jhm.2086. Epub 2013 Sep 20.
6
Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.慢性肝病住院患者的凝血障碍并不能预防静脉血栓栓塞症。
Chest. 2010 May;137(5):1145-9. doi: 10.1378/chest.09-2177. Epub 2009 Dec 29.
7
Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.接受药物性静脉血栓栓塞预防的慢性肝病和凝血障碍患者的出血风险。
Pharmacotherapy. 2014 Oct;34(10):1043-9. doi: 10.1002/phar.1464. Epub 2014 Jul 23.
8
A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.慢性肝病住院患者药物性静脉血栓栓塞预防与帕多瓦预测评分的回顾性队列分析
J Pharm Pract. 2017 Feb;30(1):58-63. doi: 10.1177/0897190015611570. Epub 2016 Jul 9.
9
Venous thromboembolism in patients with liver diseases.肝病患者的静脉血栓栓塞症。
J Thromb Haemost. 2018 Oct;16(10):2003-2007. doi: 10.1111/jth.14255. Epub 2018 Oct 3.
10
Risk factors for venous thromboembolism in patients with chronic liver disease.慢性肝病患者静脉血栓栓塞的风险因素。
Ann Pharmacother. 2013 Mar;47(3):333-9. doi: 10.1345/aph.1R496. Epub 2013 Mar 12.

引用本文的文献

1
Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study.预测肝细胞癌患者腹腔镜肝切除术后深静脉血栓形成风险的列线图构建与验证:一项回顾性研究
J Hepatocell Carcinoma. 2021 Jul 21;8:783-794. doi: 10.2147/JHC.S311970. eCollection 2021.
2
Anticoagulation in patients with advanced liver disease: an open issue.晚期肝病患者的抗凝治疗:一个未解决的问题。
Intern Emerg Med. 2021 Jan;16(1):61-71. doi: 10.1007/s11739-020-02526-6. Epub 2020 Oct 18.
3
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
在1期临床试验中,严重肝功能不全与静脉血栓栓塞事件相关。
Thromb Res. 2015 Dec;136(6):1169-73. doi: 10.1016/j.thromres.2015.10.024. Epub 2015 Oct 20.